Dow Up 0.08% Nasdaq Down 0.30%

Pharmacyclics Inc. (PCYC)

-NasdaqGS
123.52 Down 1.45(1.16%) Sep 19, 4:00PM EDT
|After Hours : 120.81 Down 2.71 (2.19%) Sep 19, 6:43PM EDT
Prev Close:124.97
Open:125.38
Bid:119.81 x 100
Ask:124.50 x 400
1y Target Est:157.88
Beta:1.12
Next Earnings Date:N/A
Day's Range:123.02 - 127.07
52wk Range:82.51 - 154.89
Volume:1,095,364
Avg Vol (3m):1,002,770
Market Cap:9.30B
P/E (ttm):71.19
EPS (ttm):1.74
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
PCYCDown 1.16%9.30B
CTICUp 0.75%387.13M
MRKUp 0.30%174.49B

Key Statistics

Forward P/E (1 yr):1,764.57
P/S (ttm):21.62
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.26
Quarterly EPS Est (Sep-14) :0.42
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):3,004.06

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Pharmacyclics, Inc., a biopharmaceutical company, designs, develops, and commercializes small-molecule drugs for the treatment of cancer and immune mediated diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback